310 related articles for article (PubMed ID: 25565812)
61. Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris.
Ochsendorf F
J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 5():8-13. PubMed ID: 26059820
[TBL] [Abstract][Full Text] [Related]
62. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
63. Niosomally encapsulated silver sulfadiazine gel for burn treatment.
Dharashivkar SS; Sahasrabuddhe SH; Saoji AN
J Microencapsul; 2015; 32(2):137-42. PubMed ID: 25265059
[TBL] [Abstract][Full Text] [Related]
64. Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole.
Ning M; Guo Y; Pan H; Chen X; Gu Z
Drug Dev Ind Pharm; 2005 May; 31(4-5):375-83. PubMed ID: 16093203
[TBL] [Abstract][Full Text] [Related]
65. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.
Kumbhar D; Wavikar P; Vavia P
AAPS PharmSciTech; 2013 Sep; 14(3):1072-82. PubMed ID: 23818079
[TBL] [Abstract][Full Text] [Related]
66. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
[TBL] [Abstract][Full Text] [Related]
67. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris.
Leyden JJ; Berger RS; Dunlap FE; Ellis CN; Connolly MA; Levy SF
Am J Clin Dermatol; 2001; 2(1):33-9. PubMed ID: 11702619
[TBL] [Abstract][Full Text] [Related]
68. Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s).
Negi P; Aggarwal M; Sharma G; Rathore C; Sharma G; Singh B; Katare OP
Biomed Pharmacother; 2017 Apr; 88():480-487. PubMed ID: 28126673
[TBL] [Abstract][Full Text] [Related]
69. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L
Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725
[TBL] [Abstract][Full Text] [Related]
70. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
71. Formulation of tretinoin-loaded topical proniosomes for treatment of acne: in-vitro characterization, skin irritation test and comparative clinical study.
Rahman SA; Abdelmalak NS; Badawi A; Elbayoumy T; Sabry N; El Ramly A
Drug Deliv; 2015; 22(6):731-9. PubMed ID: 24670094
[TBL] [Abstract][Full Text] [Related]
72. The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Sep; 12(9):1033-8. PubMed ID: 24002152
[TBL] [Abstract][Full Text] [Related]
73. A multicenter, double-blind study to evaluate the efficacy and safety of 2 treatments in participants with mild to moderate acne vulgaris.
Draelos ZD; Shalita AR; Thiboutot D; Oresajo C; Yatskayer M; Raab S
Cutis; 2012 Jun; 89(6):287-93. PubMed ID: 22838094
[TBL] [Abstract][Full Text] [Related]
74. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M;
Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769
[TBL] [Abstract][Full Text] [Related]
75. Surface modified niosomal quercetin with cationic lipid: an appropriate drug delivery system against Pseudomonas aeruginosa Infections.
Hemmati J; Chiani M; Chegini Z; Seifalian A; Arabestani MR
Sci Rep; 2024 Jun; 14(1):13362. PubMed ID: 38862754
[TBL] [Abstract][Full Text] [Related]
76. In vitro antimicrobial activity of benzoyl peroxide against Propionibacterium acnes assessed by a novel susceptibility testing method.
Okamoto K; Ikeda F; Kanayama S; Nakajima A; Matsumoto T; Ishii R; Umehara M; Gotoh N; Hayashi N; Iyoda T; Matsuzaki K; Matsumoto S; Kawashima M
J Infect Chemother; 2016 Jun; 22(6):426-9. PubMed ID: 26806150
[TBL] [Abstract][Full Text] [Related]
77. Formulation and pharmacodynamic evaluation of glibenclamide incorporated niosomal gel.
Vadlamudi HC; Yalavarthi PR; Satyanarayana RP; Vandana K; Vulava J; Gutta TC
Curr Drug Discov Technol; 2014; 11(3):189-96. PubMed ID: 25176281
[TBL] [Abstract][Full Text] [Related]
78. Innovative topical niosomal gel formulation containing diclofenac sodium (niofenac).
Akbari J; Saeedi M; Morteza-Semnani K; Hashemi SMH; Babaei A; Eghbali M; Mohammadi M; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
J Drug Target; 2022 Jan; 30(1):108-117. PubMed ID: 34116599
[TBL] [Abstract][Full Text] [Related]
79. Intradermal and follicular delivery of adapalene liposomes.
Kumar V; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
[TBL] [Abstract][Full Text] [Related]
80. The evolution of benzoyl peroxide therapy.
Tanghetti E
Cutis; 2008 Nov; 82(5 Suppl):5-11. PubMed ID: 19202772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
